Tim McCarthy, CEO of ImmuPharma, talks to Proactive Investor on the recent Company ‘Corporate Update’, the refocused product development portfolio and the positive corporate structure changes – 4 October 2021
This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy
